• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

COVID-19’s Impact on Telehealth & HIPAA Regulations

Share:

March 24, 2020

The declaration of COVID19 as a pandemic and the United States declaring a national emergency to help contain and enhance treatment access have resulted in a number of changes to ease potential regulatory burdens or barriers in healthcare. Like so much happening as a result of the pandemic, the changes have the potential to fundamentally change the healthcare industry not just during the time of the emergency declaration.

Of particular note are coordinated announcements from various agencies within the federal Department of Health and Human Services connected to the provision of telehealth services. The advancement and relaxation of regulations are designed to increase access to telehealth services and make it easier to deliver the services.

The scope of telehealth services now available, as explained by the Centers for Medicare and Medicaid Services (CMS), can be broken into three main categories: (i) telehealth visits, (ii) virtual check-ins, and (iii) e-visits.

Telehealth Visits – For purposes of Medicare, a telehealth visit is between a patient and a clinician that uses interactive audio and video. The visits generally cover visits that could otherwise occur in person. As such, the telehealth visit is being structured as a replacement for an office visit for the time being. The telecommunication platform must provide real-time communication between the patient and the clinician. CMS will also turn a blind eye to the established patient requirement, which essentially means a telehealth visit can occur with both new and established patients. Additionally, a patient will be permitted to receive telehealth services while in their home, which reinforces the goal of maintaining social distancing.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Virtual Check-Ins – A virtual check-in is meant to be a brief discussion between a clinician and a patient, which can be audio-only. Further, CMS expects that in most instances the patient will be the one to initiate a check-in. The check-in cannot be related to an office visit from the previous 7 days or lead to a full visit within 24 hours after the check-in. Additionally, the patient must verbally agree to the check-in. Lastly, check-in is only billable for an established patient, which follows from the description of the service as being focused on a quick interaction between a patient and their clinician.

E-Visit – An e-visit is similar to a virtual check-in, but must be patient-initiated and is expected to occur through the patient portal. Further, the service can cover up to a 7 day period between the communication initiated by the patient and interactions with the clinician. Before being able to bill for the e-visit, the patient must be established with the clinician and made aware of the fact that reimbursement will be sought for the services.

On top of opening up the scope and ability to provide telehealth based visits, a bigger change is to reimburse the telehealth visits at the same level as in-person visits. Arguably, one of the primary barriers to telehealth adoption up until this point has been a lack of or lower reimbursement. The incentivization of patient interactions through telehealth means not only with healthcare organizations potentially be able to somewhat mitigate the financial fallout from telling patients to remain home, but gives a good alternative that could stabilize access. Stabilizing access is important since reducing non-emergent issues cannot be put off indefinitely.

Read more

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • UNIVERSITY OF ARKANSAS LAUNCHES STATEWIDE, DIGITAL HEALTH SPINE CLINICUNIVERSITY OF ARKANSAS LAUNCHES STATEWIDE, DIGITAL HEALTH SPINE CLINIC
  • Assertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain ProductsAssertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain Products
  • Bio-Techne to Acquire LunaphoreBio-Techne to Acquire Lunaphore
  • Octave Bags $11m Series A for In-person, Virtual Behavioral CareOctave Bags $11m Series A for In-person, Virtual Behavioral Care
  • Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinTheraGilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera
  • Headway Expands Nationwide, Connecting Mental Health Patients with Care in All 50 StatesHeadway Expands Nationwide, Connecting Mental Health Patients with Care in All 50 States
  • Global Vinpocetine Market Insights 2019-2025 | Gedeon, Richter, Runhong, Sun Pharma, WZTGlobal Vinpocetine Market Insights 2019-2025 | Gedeon, Richter, Runhong, Sun Pharma, WZT
  • Amedisys Completes Acquisition of Asana HospiceAmedisys Completes Acquisition of Asana Hospice

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications